IndiGo's Chief Human Resources Officer, Sukhjit Singh Pasricha, has resigned after an eight-year tenure, with Kanwal Jeet Singh Bakshi set ...

While Manish Singhal remains a designated “key person” in the fund, Pi Ventures has witnessed several senior-level exits over the past five...

NRI accounts are surging even as stricter compliance and a softer market cool equity inflows. This and more in today’s ETtech Morning Dispa...

Zee Entertainment has secured a significant Rs 418 crore foreign investment from OFI Global China Fund LLC, marking the fund's return after...

Promoters and large shareholders are cashing in on a stock market rebound, offloading shares worth over ₹24,000 crore in May and June. This...

India's private banking sector faces pivotal moments with two major players at different junctures. HDFC Bank awaits RBI's nod for its CEO,...

Analysts at Nomura and Jefferies, however, maintain 'Buy' ratings, with Nomura highlighting Anup Kumar Saha as a strong internal candidate....

In a surprising announcement, Ashok Vaswani, CEO and Managing Director at Kotak Mahindra Bank, has decided to step down on December 31, 202...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Foreign investors have withdrawn over $60 billion from Indian equities, prompting concerns that retail investors are funding their exits. H...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...